A 6-month follow-up study of the randomized controlled Ma-Pi macrobiotic dietary intervention (MADIAB trial) in type 2 diabetes.

A SoareR Del ToroY M KhazraiA Di MauroS FalluccaS AngelettiEdlira SkramiR GesuitaD TuccinardiS ManfriniF FalluccaM PianesiP Pozzilli

Published in: Nutrition & diabetes (2016)

Both the Ma-Pi and control diets maintained their benefits beyond the 21-day intensive monitored intervention over a 6-month follow-up in real-world conditions. The Ma-Pi diet resulted in greater improvement in glycemic control.

Keyphrases

glycemic control
type diabetes
weight loss
phase iii
randomized controlled trial
blood glucose
phase ii
open label
clinical trial
double blind
insulin resistance
study protocol
cardiovascular disease
placebo controlled
metabolic syndrome